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Several biologically important growth factor–heparan sulfate (HS) interactions are regulated by HS
sulfation patterns. However, the biogenesis of these combinatorial sulfation patterns is largely
unknown. N-Deacetylase/N-sulfotrasferase (NDST) converts N-acetyl-D-glucosamine residues to N-
sulfo-D-glucosamine residues. This enzyme is suggested to be a gateway enzyme because N-sulfation
dictates the ﬁnal HS sulfation pattern. It is known that O-sulfation blocks C5-epimerase, which acts
immediately after NDST action. However, it is still unknown whether O-sulfation inhibits NDST
action in a similar manner. In this article we radically change conventional assumptions regarding
HS biosynthesis by providing in vitro evidence that N-sulfation is not necessarily just a gateway
modiﬁcation during HS biosynthesis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heparan sulfate proteoglycans (HSPGs) are composed of core
proteins attached to sulfated glycosaminoglycan (GAG) side chains.
They play important roles as co-receptors for several molecules
including ﬁbroblast growth factors (FGF), hepatocyte growth factor
(HGF), glial cell derived neurotrophic factor (GDNF), and vascular
endothelial growth factors (VEGF) [1]. By acting as co-receptors,
they are involved in a variety of pathological and physiological pro-
cesses such as tumor progression and embryonic development [2–
4]. The role of HS as a co-receptor depends greatly on its sulfation
pattern. For example, HS–FGF2 interactions require the presence of
N-sulfated glucosamine units, 2-O sulfated iduronic acid units, and
6-O sulfated glucosamine units [5,6].
To generate the diverse sulfation patterns present in HS chains,
the biosynthesis of HS involves a complex interplay between several
enzymes that are predicted to be co-localized within GAGOSOMEs
[7–12].HSbiosynthesisbeginswith the formationofa linkage region
composed of one xylose residue, two galactose residues and one
glucuronic acid residue. Next, the HS chain is extended by Ext-1
andExt-2.As thepolymerizationtakesplace,N-deacetylase/N-sulfo-
trasferase enzyme isoforms (NDST) convertN-acetyl-D-glucosamine
residues in the nascent chain into N-sulfo-D-glucosamine residues.chemical Societies. Published by E
000 E, Skaggs Hall Room 307,
. Kuberan).There are four known NDST isoforms that have different deacetyla-
tion/sulfation abilities andare expressedvariably indifferent tissues
[13–17]. The N-sulfate groups added by these enzymes determine
the domain structure of HS because subsequent modiﬁcations by
C5-epimerase, 2-O sulfotransferase, 3-O sulfotransferase, and 6-O
sulfotransferase are dictated by the location of N-sulfate groups
[18]. The order of modiﬁcations will have enormous implications
in generating diverse structures of biological signiﬁcance [19].
It is well known that C5-epimerase, which converts glucuronic
acid residues to iduronic acid residues after NDST modiﬁcation, is
inhibited by O-sulfation [20]. However, it is unknown whether
NDST, which confers the ﬁrst modiﬁcation of HS chains, is inﬂu-
enced similarly by the presence of nearby O-sulfate groups. Earlier
studies have shown that NDST can act on a variety of substrates
[21–28]. However, these studies have not elucidated the site of ac-
tion of NDST within the larger heparanome (which contains non-
sulfated (NA), heavily sulfated (NS) and mixed (NA/NS) domains).
Earlier studies estimated the levels of radioactive [35S]-sulfate
incorporation into a variety of substrates in the presence of NDST
without analyzing the corresponding disaccharides. Therefore, it
is unknown whether O-sulfation inhibits NDST activity, i.e. NDST
could just be modifying N-acetyl glucosamine (GlcNAc) residues
in the non-sulfated NA domains within the heparanome.
This study utilizes NDST-2, a robust enzyme isoform which
shows equal N-deacetylase and N-sulfotransferase activity, to
determine the site of action of NDST on HS for the ﬁrst time and
to probe whether O-sulfation affects N-deactylation/N-sulfation.lsevier B.V. All rights reserved.
Fig. 1. Radiometric traces of disaccharides formed by digesting polysaccharides
with Heparitinases I, II, and III. (a) Disaccharides formed when HS is treated with
NDST-2 and digested with Heparitinases I, II, and III. (b) Disaccharides of partially
N-sulfated, 6-O sulfated heparosan, a synthetic substrate designed to test the
activity of NDST-2 without neighboring group effects from other O-sulfates. The
ratio of GlcNS6S/GlcNAc6S peaks is 0.6. (c) Disaccharides of NDST-2 treated
partially N-sulfated, 6-O sulfated heparosan. After NDST-2 addition, the GlcNS6S/
GlcNAc6S ratio increases. Thus 6-O sulfation does not inhibit NDST-2 action. The
peaks in the chromatograms were determined by comparison to co-injected
standards.
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NDST-2 on a mature HS chain and on a synthetic enzymatically-
generated substrate.
2. Materials and methods
2.1. Materials
Heparan sulfate from bovine kidney was procured from Sei-
kagaku. DEAE-Sepharose gel was purchased from Amersham Bio-
sciences. [35S]Na2SO4 and Ultima-FloAP scintillation ﬂuid were
purchased from Perkin Elmer Life and Analytical Sciences. [32S]PAPS
and HS disaccharide standards were purchased from Iduron and
Sigma–Aldrich. SF-900 II SFM media was purchased from Invitro-
gen. [35S]PAPS was prepared as reported earlier [19]. Heparitinases
I, II, and III from ﬂavobacterium heparinum were cloned and ex-
pressed as previously described. All other reagents and solvents
were from Sigma–Aldrich.
2.2. Puriﬁcation of NDST-2
Fifteen millilitres of NDST-2 viral stock was added to 2  109 Sf9
cells in 1 l of SF900 II SFM media. Infected cells were shaken at a
rate of 150 rpm in a humidiﬁed incubator maintained at 28 C for
4 days. After 4 days, the cell suspension was centrifuged at
1000g for 30 min to pellet cells. To the supernatant, PIPES solu-
tion was added to a ﬁnal concentration of 10 mM and the pH of
the solution was adjusted to 7.0. Next, a solution containing phen-
ylmethylsulfonyl ﬂuoride in 10 ml isopropanol was added to a ﬁnal
concentration of 1 mM. The supernatant was then chilled on ice for
1 h prior to centrifugation at 4000g for 1 h. The supernatant was
then diluted 1:2 with ddH2O and ﬁltered through a 0.45 lm pore-
size PES membrane under vacuum. This solution was then loaded
onto a 100-ml column of ToyoPearl AF heparin 650 M. The column
was washed with 600 ml of PCG-50 (10 mM PIPES, pH 7.0, 2% glyc-
erol, 0.6% CHAPS, 50 mM NaCl) and eluted with a 450-ml linear
gradient of 50–1000 mMNaCl in PCG. Aliquots of selected fractions
were then analyzed to check NDST-activity as described later in the
methods section utilizing a heparan sulfate substrate instead of
K5NS. Positive fractions were then pooled and concentrated using
an Amicon YM-10 membrane.
2.3. Preparation of partially N-sulfated 6-O-sulfated K5 heparosan
All reactions were performed in a buffer consisting of 25 mM
MES (pH 7.0), 0.02% Triton X-100, 2.5 mM MgCl2, 2.5 mM MnCl2,
1.25 mM CaCl2 and 0.75 mg/ml BSA. Four hundred and eighty
micrograms of K5 heparosan was combined with 200 lg of
[32S]PAPS and 40 ll of NDST-2 in a 600 ll reaction volume. The
product was analyzed after digestion with Heparitinases I, II, and
III, using strong anion exchange HPLC (SAX-HPLC) with an inline
UV detector measuring absorbance at 232 nm. Ten micrograms of
partially N-sulfated K5 heparosan was incubated with 10 ll of 6-
OST-3 and 3 ll of [35S]PAPS (0.5  107 CPM) in a 50 ll reaction.
An aliquot of the radioactive sample was then desalted through a
3000 MWCOﬁlter, digestedwith Heparitinases I, II, and III, and ana-
lyzed using SAX-HPLC with an inline radiometry detector. Radioac-
tive disaccharides were eluted with a linear gradient of 0–1 M NaCl
in 70 mM phosphate buffer (pH 3.0) for 60 min and co-injected HS
disaccharide standards were used to conﬁrm their identity.
2.4. Enzymatic reactions of NDST-2
Heparan sulfate or K5NAc/NS6S were treated with NDST-2 by
incubating 10 lg of substrate with 10 ll of NDST-2, 10 ll of MES,
and 3 ll of [35S]PAPS (0.5  107 CPM) in a 50 ll reaction overnight.The next day, an additional 10 lg of [32S]PAPS was added along
with 10 ll of NDST-2 to saturate all possible modiﬁcation sites.
The modiﬁed products were then desalted, digested, and analyzed.
3. Results and discussion
To demonstrate that N-sulfation is not just a gateway modiﬁca-
tion and to elucidate the site of action of NDST enzymes on a ma-
ture HS chain, bovine kidney HS was incubated with NDST-2 in the
presence of [35S]PAPS. The resulting polymer chain was treated
with Heparitinases I, II, and III, and the resulting radio-labeled
disaccharides were co-injected with disaccharide standards and
analyzed by strong anion exchange chromatography (Fig. 1a). A
chromatogram of the HS from bovine kidney is included in the
Supplementary materials (Fig. S1).
After NDST-2 treatment of HS, the disaccharides generated by
heparitinase treatment are: DUA-GlcN[35S] and DUA-GlcN[35S]6S
3422 K. Raman et al. / FEBS Letters 585 (2011) 3420–3423Thus, onlyDUA-GlcNAc andDUA-GlcNAc6S residues on mature HS
chains can be N-sulfated. Surprisingly, the HS chains did not have
any additional modiﬁcation sites. One would expect that small
amounts of (GlcA/IdoA)2S-GlcNAc sequences would also be sul-
fated by NDST, however the expected disaccharide product,
DUA2S-GlcN[35S], was not found after digestion of the polysaccha-
rides with Heparitinases I, II, and III. This observation points to the
possibility that other O-sulfates may inhibit NDST action. However,
such a claim is difﬁcult to test because of the rare nature of N-acet-
ylated 2-O sulfated disaccharide units and the difﬁculties involved
in synthesizing such substrates using chemoenzymatic methods.
While NDST was found to act on 6-O sulfated residues in HS, it is
difﬁcult to analyze the true sites of modiﬁcation because nearby
sulfate groups can inﬂuence the action of the enzyme on the poly-
mer chain. To further conﬁrm the hypothesis that NDST modiﬁes
GlcNAc6S sites on HS, and to negate any such neighboring group
effects, a synthetic substrate consisting of this residue was synthe-
sized by 6-O-sulfation of 50% N-sulfated heparosan with 6-OST-3
in the presence of [35S]PAPS (Fig. 2, polysaccharide 1). Treating this
polysaccharide with NDST-2 in the presence of [32S]PAPS then al-
lowed us to observe the conversion of GlcNAc6[35S] residues to
GlcNS6[35S] residues (Fig. 1b and c). It is noteworthy that all Glc-
NAc6[35S] residues were converted to GlcNS6[35S] residues – con-
ﬁrming that 6-O-sulfation does not inhibit NDST enzymatic action.Fig. 3. The comparative effect of O-sulfation on the action of NDST and C5-
epimerase. After the formation of the linkage region and subsequent polymeriza-
tion, NDST enzymes add on the ﬁrst sulfate residues onto a nascent chain. C5-
Epimerase and several O-sulfotransferases then further modify the HS chain. C5-
Epimerase cannot act on this mature chain due to O-sulfates which block its
activity. However, NDST can still act on this substrate and thus N-sulfation is much
more than just a gateway modiﬁcation during heparan sulfate biosynthesis.
Fig. 2. Modiﬁcation of polysaccharide 1 by NDST. (⁄) Indicates that this sulfate
group is [35S] and the radiolabeled product, after digestion with Heparitinases I, II,
and III, are resolved and visualized on the radiochromatogram shown in Fig. 1.Based on these results, it is evident that the conventional view
of NDST, as a gateway enzyme, provides incomplete information.
This study provides in vitro evidence showing that NDST acts on
the mature HS chain and modiﬁes it after it has been 6-O-sulfated
– thus NDST-mediated modiﬁcation is not necessarily just a gate-
way modiﬁcation during HS biosynthesis (see Fig. 3). Extending
the ﬁndings reported here to probe the action of NDST in vivo is be-
yond the scope of the current work. Nevertheless, one can conclu-
sively state that current and previously reported in vitro
experiments have undoubtedly helped demonstrate that O-sulfa-
tion differentially affects the action of two early biosynthetic en-
zymes, NDST and C5-epimerase [9,20]. One can envision that
in vivo evidence delineating the exact sequence of HS biosynthetic
events and the exact action of biosynthetic enzymes may require
complex cellular experiments involving isotope enriched mole-
cules and sophisticated instruments [29]. In conclusion, the results
of this study redeﬁne the role of NDST during HS biosynthesis and
provide new insights into the actions of GAGOSOMES.Acknowledgements
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